Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects
Clinical trial NCT04793295 · COMPLETED
Trial details
- NCT number
- NCT04793295
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2022-02-04
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.